Risk of cardiovascular death in relation to blood pressure levels in Tyumen men and women: results of a 12-year prospective study


Cite item

Full Text

Abstract

AIM: To evaluate the effect of blood pressures (BP) on the risk of cardiovascular death (CVD) in a Tyumen open population through a 12-year prospective follow-up study/MATERIAL AND METHODS: Standard methods were used to make a cardiac screening of a representative sample of 25-to-64-year-old Tyumen citizens in 1996. The response rate was 80.4% or 1608 persons. CVD cases were recorded in 85 (10.69%) men and 33 (4.06%) women during the 12-year subsequent prospective follow-up study. The Cox regression model was used to assess the relative risk (RR) for CVD. Survival rates were analyzed with the Kaplan-Meier method/RESULTS: In the men, RR for CVD statistically significant increased from the 4th quintile of the distribution of systolic blood pressure (SBP) (2.88) and from the 3rd quintile of that of diastolic BP (DBP) (2.33). The women showed a statistically significant increase in RR for CVD only in the 5th quintile both of SBP and DBP (11.0 and 7.95%, respectively). Analysis of the absolute risk showed that SBP made a greater contribution to CVD that DBP in both the men and women (52.8 and 46.9% for the men and 92 and 83.8% for the women, respectively)/CONCLUSION: The open population from Tyumen was ascertained to have a high RR for CVD starting with a SBP of ≥141 mm Hg and a DBP ≥86 mm Hg for the men and with a SBP of ≥152 mm Hg and a DBP of ≥95 mm Hg for the women, which determined a lower survival in the population with elevated SBP and elevated DBP.

About the authors

E V Akimova

Филиал НИИ кардиологии СО РАМН Тюменский кардиологический центр; Межведомственная лаборатория эпидемиологии сердечно-сосудистых заболеваний СО РАМН, Тюмень

Email: akimova@cardio.tmn.ru

G S Pushkarev

Филиал НИИ кардиологии СО РАМН Тюменский кардиологический центр; Межведомственная лаборатория эпидемиологии сердечно-сосудистых заболеваний СО РАМН, Тюмень

V V Gafarov

Межведомственная лаборатория эпидемиологии сердечно-сосудистых заболеваний СО РАМН, Тюмень

V A Kuznetsov

Филиал НИИ кардиологии СО РАМН Тюменский кардиологический центр

References

  1. Оганов Р.Г., Калинина А.М., Поздняков Ю.М. Профилактическая кардиология. М 2003.
  2. Агеев Ф.Т., Фомин И.В., Мареев В.Ю., Беленков Ю.Н. Распространенность артериальной гипертонии в европейской части Российской Федерации. Данные исследования ЭПОХА, 2003 г. Кардиология 2004; 11: 50-54.
  3. Акимова Е.В., Кузнецов В.А., Гафаров В.В. и др. Некоторые поведенческие факторы риска развития сердечно-сосудистых заболеваний у мужчин средних возрастных групп. Тер арх 2009; 1: 56-60.
  4. Оганов Р.Г., Шальнова С.А., Деев А.Д. и др. Артериальная гипертония и ее вклад в смертность от сердечно-сосудистых заболеваний. Проф забол и укреп здор 2001; 4: 11-15.
  5. Акимова Е.В., Гакова Е.И., Каюмов Р.Х. и др. Некоторые компоненты метаболического синдрома у молодых мужчин открытой популяции Тюмени. Сибирский мед журн 2011; 2: 140-143.
  6. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М: Медиа Сфера 2002.
  7. Multiple Risk Factor Intervention Trial Research Group. Mortality after 16 years for participants randomized to the multiple risk factor intervention trial. Circulation 1996; 94: 946-951.
  8. Glynn R.J., L'Italien G.J., Sesso H.D. et al. Development of predictive for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002; 39: 105-110.
  9. Kannel W.B., Dawber T.R., McGee Kannel D.L. Perspectives on systolic hypertension: The Framingham Study. Circulation 1980; 61: 1179-1182.
  10. Sleight P. Isolated systolic hypertension: the WISHE study. Eur Heart J 1999; 1 (Suppl. P): P17-P20.
  11. Stamler J., Stamler R., Neaton J.D. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993; 153: 598-615.
  12. Port S., Garfinkel A., Boyle N. There is a non-linear relationship between mortality and blood pressure. Eur Heart J 2000; 21: 1635-1638.
  13. Шальнова С.А., Баланова Ю.А., Константинов В.В. и др. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. Рос кардиол журн 2006; 4: 45-50.
  14. Kannel W.B. Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J 1992; 13: 82-88.

Copyright (c) 2013 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies